Renal responses to AT1 receptor blockade

被引:50
|
作者
Navar, LG [1 ]
Harrison-Bernard, LM [1 ]
Imig, JD [1 ]
Cervenka, L [1 ]
Mitchell, KD [1 ]
机构
[1] Tulane Univ, Sch Med, Dept Physiol SL39, New Orleans, LA 70112 USA
关键词
tubular Ang II concentration; two-kidney one-clip Goldblatt hypertension; candesartan; renal hypertension; sodium excretion; renal hemodynamics;
D O I
10.1016/S0895-7061(99)00248-4
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Because of the importance of the renin-angiotensin system in the pathophysiology of hypertension and in mediating associated alterations in renal function, angiotensin II (Ang II) AT(1) receptor blockers provide a direct means of protecting against influences of excessive Ang II levels. The kidney is an important site of action of Ang II AT(1) receptor blockers because intrarenal Ang II not only vasoconstricts the renal vasculature but also reduces sodium excretion and suppresses the pressure natriuresis relationship. Even in normal conditions, intrarenal Ang II content is greater than can be explained on the basis of circulating Ang II and is compartmentalized with proximal tubule concentrations of Ang I and Ang II being several times higher than plasma concentrations. The localization of angiotensinogen in proximal tubule cells further supports the concept that the proximal tubule secretes Ang II or precursors of Ang II into the tubular fluid to activate luminal Ang II receptors. Recent immunohistochemical studies have demonstrated an abundance of AT(1) receptors on the luminal surface of proximal and distal tubule cells as well as on vascular smooth muscle cells of afferent and efferent arterioles and on glomerular mesangial cells. Activation of luminal AT(1) receptors stimulates the sodium hydrogen exchanger and increases reabsorption rate. The prominence of AT(1) receptors in vascular and epithelial tissues in the kidney provides the basis for the powerful effects of AT(1) receptor blockers on renal function especially in hypertensive conditions. In the two-kidney, one-clip (2K1C) Goldblatt hypertensive rat model, the nonclipped kidney is renin depleted but the intrarenal Ang II levels are not suppressed and Ang II concentrations in proximal tubular fluid remain high (10(-8) mol/L). AT(1) receptor blockers such as candesartan have been shown to cause significant increases in glomerular filtration rate, renal blood flow and proportionately much greater increases in sodium excretion and fractional sodium excretion. Ang II blockade also markedly increases the slope of the pressure natriuresis relationship. The collective actions of Ang II blockers on tubular transport and renal hemodynamics provide long-term effects to regulate sodium balance, which contributes to the long-term control of hypertension. Am J Hypertens 2000;13345S-54S (C) 2000 American Journal of Hypertension, Ltd.
引用
收藏
页码:45S / 54S
页数:10
相关论文
共 50 条
  • [31] Anti-atherosclerotic effects by AT1 receptor blockade
    de Faire, U
    JOURNAL OF HYPERTENSION, 2003, 21 (02) : 259 - 260
  • [32] CHRONIC AT1 RECEPTOR BLOCKADE IN OBESE ZUCKER RATS
    ALONSOGALICIA, M
    BRANDS, MW
    SMITH, MJ
    ZAPPE, DH
    HALL, JE
    FASEB JOURNAL, 1995, 9 (03): : A296 - A296
  • [33] Therapeutic effects of angiotensin (AT1) receptor antagonists: Potential contribution of mechanisms other than AT1 receptor blockade
    Schmidt B.
    Drexler H.
    Schieffer B.
    American Journal of Cardiovascular Drugs, 2004, 4 (6) : 361 - 368
  • [34] Angiotensin AT1 receptor (AT1R) blockade mediates a renal bradykinin (BK)-nitric oxide (NO) cascade
    Siragy, HM
    de Gasparo, M
    Carey, RM
    HYPERTENSION, 1998, 32 (03) : 629 - 629
  • [35] Morphological and functional pattern of vascular responses after AT1 receptor blockade started at prehypertensive period of SHR
    Koprdova, R.
    Cebova, M.
    Torok, J.
    Kristek, F.
    EUROPEAN HEART JOURNAL, 2006, 27 : 122 - 122
  • [36] Intrarenal Blockade of Angiotensin II AT1 Receptor Abolishes Renal Cortical Hypoxia in Salt Restricted Animals
    Patinha, Daniela
    Pihl, Liselotte
    Palm, Fredrik
    FASEB JOURNAL, 2015, 29
  • [37] Reciprocal role of the AT1 receptor in modulating renal and neuronal AT1 mRNA expression
    Li, JP
    Zhao, HW
    Dipette, DJ
    Supowit, SC
    Wang, DH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 : S18 - S22
  • [38] Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye
    Prasad, Tuhina
    Roksnoer, Lodi C. W.
    Zhu, Ping
    Verma, Amrisha
    Li, Yiming
    Batenburg, Wendy W.
    de Vries, Rene
    Danser, A. H. Jan
    Li, Qiuhong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (15) : 6722 - 6730
  • [39] Effect of AT1 receptor blockade on endothelial function in essential hypertension
    Klingbeil, AU
    John, S
    Schneider, MP
    Jacobi, J
    Handrock, R
    Schmieder, RE
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (02) : 123 - 128
  • [40] Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
    Benicky, Julius
    Sanchez-Lemus, Enrique
    Honda, Masaru
    Pang, Tao
    Orecna, Martina
    Wang, Juan
    Leng, Yan
    Chuang, De-Maw
    Saavedra, Juan M.
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (04) : 857 - 870